Aims: To determine the mechanism of action of antimicrobial protein, lactosporin, against Gardnerella vaginalis and to evaluate its safety in vitro. Methods and Results: Bacillus coagulans ATCC 7050 was grown at 37°C for 18 h. The cell-free supernatant was concentrated 10-fold and screened for antimicrobial activity against indicator strain Micrococcus luteus. The mode of action of lactosporin was determined by measuring the potassium release and monitoring the changes in transmembrane potential (Dw) and transmembrane pH (DpH) of the sensitive cells. Lactosporin caused the efflux of potassium ions from M. luteus cells and dissipation of DpH in G. vaginalis, while it had no effect on the Dw. The safety of lactosporin was evaluated by using EpiVaginal TM ectocervical (VEC-100) tissue model. Over 80% of the cells in the vaginal tissue remained viable after exposure to lactosporin for 24 h. Conclusions: Lactosporin potentially exerts its antimicrobial activity by selective dissipation of DpH and/or by causing leakage of ions from the sensitive cells. Safety studies suggest that lactosporin is a noncytotoxic antimicrobial for vaginal application. Significance and Impact of the Study: This study revealed that lactosporin is an effective and safe antimicrobial preparation with potential application for the control of bacterial vaginosis.
Introduction
Bacteriocins are ribosomally synthesized antimicrobial compounds of proteinaceous nature produced by virtually all micro-organisms that act against closely related species (Klaenhammer 1993) . Bacteriocins produced by lactic acid bacteria (LAB) have received great attention in the past decade owing to their potential applications as food preservatives (Cleveland et al. 2001) . Production of bacteriocins and bacteriocin-like inhibitory substances (BLIS) from the Bacillus genus has been studied by several research groups (e.g. Babasaki et al. 1985; Stein et al. 2004; Shelburne et al. 2007; Sutyak et al. 2008; Sutyak Noll et al. 2011) . Many bacteriocins and BLIS kill sensitive cells by a common mechanism of action through the formation of a transient pore in the cytoplasmic membrane resulting in the leakage of small intracellular compounds and dissipation of proton motive force (PMF) component(s). PMF is an electrochemical proton gradient across the cytoplasmic membrane which is composed of two components: membrane potential (Dw) and pH gradient (DpH). PMF is directly involved in a number of biological processes such as ATP synthesis, active ion transport, protein phosphorylation and bacterial motility (Montville and Bruno 1994; Montville and Chen 1998) . Antimicrobial proteins may deplete either or both components of PMF and cause intracellular ATP depletion by either efflux or intracellular ATP hydrolysis (Chen and Montville 1995) .
Lactosporin is a novel antimicrobial protein produced by a strain of Bacillus coagulans isolated from a dietary supplement, Lactospore ® Probiotic (Sabinsa Corp., East
Windsor, NJ, USA). Previous work has studied the characterization of this antimicrobial protein including inhibitory spectrum, pH, temperature and enzyme sensitivity, isoelectric point determination, antimicrobial activity visualization by SDS and native-PAGE and PCR analysis (Riazi et al. 2009 ). Lactosporin may have applications in feminine care products because of its antimicrobial activity against Gardnerella vaginalis (Riazi et al. 2009 ), one of the most frequent causative organisms in bacterial vaginosis (BV) (Turovskiy et al. 2011) . BV is one of the most common infections in women of reproductive age, and approximately 10-15% of the female population are affected by this infection (Persaud et al. 2006) . Effective BV treatment should avoid a negative impact on the healthy vaginal microflora such as Lactobacillus spp. Conventional treatments of BV with antibiotics such as metronidazole and clindamycin may have negative impact on the growth of vaginal lactobacilli (Aroutcheva et al. 2001) , while lactosporin has no inhibitory effects against the healthy vaginal microflora (Riazi et al. 2009 ). The aim of this research was to study the mechanism of action of lactosporin against G. vaginalis and to evaluate the safety of lactosporin in vitro using the EpiVaginal tissue model from MatTek Corporation (Ashland, MA, USA).
Materials and methods

Bacterial strains and growth condition
Producer strain B. coagulans ATCC 7050 was grown aerobically at 37°C in Difco Lactobacilli MRS broth (Becton, Dickinson, Franklin Lakes, NJ) with aeration for 24 h. The indicator strain M. luteus ATCC 10420 was cultured aerobically in tryptic soy broth (Becton, Dickinson) (enriched with 6 g l À1 yeast extract and 2Á5 g l À1 glucose) at 30°C. Micrococcus luteus is frequently used as an indicator micro-organism in bacteriocin detection assay (Li et al. 2005; Wirawan et al. 2006; Riazi et al. 2007) . G. vaginalis ATCC 14018 was grown on a selective human blood Tween bilayer agar medium at 37°C, anaerobically. The cultures used in this study were maintained as frozen stocks at À80°C in a biofreezer.
Production and inhibitory activity of lactosporin
The production of lactosporin was carried out as described by Riazi et al. (2009) . For the mode of action and safety assays reported in this paper, the same batch (lot# 2/3) of lactosporin preparation was used (previously used for lactosporin characterization studies). Lactosporin samples were further concentrated by lyophilization (Freeze-dryer 4.5; Labconco, Kansas City, MO) for both mode of action and safety experiments. The antimicrobial activity of lactosporin was confirmed by a well diffusion assay against M. luteus ATCC and G. vaginalis, as described by Cintas et al. (1995) . In all experiments, nisin A was used as a positive control. The commercial preparation (Sigma, St Louis, MO, USA) contains 2Á5% nisin A in denatured milk solids and was solubilized using nisin diluent (HCl solution at pH 1Á7).
Measurement of arbitrary units of activity (AU)
An arbitrary unit is defined as the reciprocal of the highest dilution showing inhibition against the indicator micro-organism (Kojic et al. 1991) . Ten 2-fold dilutions of lactosporin were made and tested for activity in well diffusion assay against M. luteus. AU ml À1 was calculated based on the highest dilution with antimicrobial activity.
Measurement of potassium release
The measurement of potassium efflux was performed as described by Orlov et al. (2002) with some modifications. A potassium-selective electrode (Phoenix Electrode Company, Houston, TX, USA) was used to measure the K + ion release from the M. luteus ATCC 10420 after treatment with lactosporin or nisin. Micrococcus luteus was grown in trypticase soy broth enriched with 2Á5 g l À1 glucose and 6 g l À1 yeast extract. Twenty ml of culture was incubated aerobically at 37°C until an optical density (OD 600 ) of 1-1Á2 was reached. The cells were washed three times (5000 g, 10 min, 4°C) with 20 ml of a 10-mmol l
À1
Tris-acetate buffer solution containing 100 mmol l À1 NaCl, pH 7Á4. The washed cells were resuspended in 5 ml of the same buffer and kept on ice until use. The electrode was calibrated with 0Á01, 0Á1 and 1 mmol l À1 solutions of KCl in 100 mmol l À1 NaCl before each experiment, and the measurements were performed in small (10 ml) pyrex beakers (Fisher Scientific, Waltham, MA) that contained a small magnetic stirrer. A 500 ll of a 20 times concentrated (320 AU) and dialysed lactosporin or a 500 ll of a 10 mg ml À1 nisin A solution was added to each beaker contacting 5 ml of the cells, and the potassium release was measured every minute for 5 min. Nisin diluent and MRS medium were used as controls for this experiment.
Dissipation of transmembrane potential (Dw)
The changes in transmembrane potential (Dw) of intact G. vaginalis cells were determined according to the protocol outlined by Sims et al. (1974) and modified by Turovskiy et al. (2009) . Briefly, G. vaginalis cells were grown anaerobically at 37°C in BHI medium supplemented with 3% horse serum to an OD 600 of 0Á6. Twenty ml of the culture was harvested by centrifugation (5000 g, 10 min, 22°C) followed by a wash step with 20 ml of fresh growth medium and resuspension in 200 ll of the same medium at room temperature. A Perkin Elmer LS-50B spectrofluorometer (Perkin Elmer Inc, Boston, MA, USA) was used to evaluate the changes in the Dw of the cells with excitation and emission wavelengths of 643 and 666 nm, respectively, and a slit width of 10 nm.
In quartz cuvettes with a 10-mm light path, 5 ll of the fluorescent probe 3,3′-dipropylthiadicarbocyanine iodide (DiSC 3 (5)) (Molecular Probes, Eugene, OR, USA) was added to 2 ml of fresh BHI broth supplemented with 3% horse serum followed by the addition of 20 ll of the cell suspension, which caused a substantial decrease in fluorescence intensity. After the signal was stabilized, 2 ll of 5 mmol l À1 nigericin (Sigma) was added to convert the DpH to Dw. After the signal was equilibrated, either lactosporin, nisin (positive control), lactosporin diluent (MRS medium) or nisin diluent (negative controls) was added to each cuvette. This step was followed by an addition of 2 ll of 2 mmol l À1 valinomycin (Sigma) to dissipate the remaining Dw.
Dissipation of the pH gradient (DpH)
The changes in transmembrane pH (DpH) of G. vaginalis cells caused by lactosporin were studied according to the protocol outlined by Molenaar et al. (1991) and the modifications made by Turovskiy et al. (2009) . Briefly, G. vaginalis was inoculated in 20 ml of fresh BHI medium supplemented with 3% horse serum and grown anaerobically at 37°C to an OD 600 of 0Á6. The cells were harvested by centrifugation (5000 g, 10 min, 22°C), washed twice with 50 mmol l À1 potassium phosphate buffer (PPB, pH 6Á0) and resuspended in 200 ll of PPB. BCECF-AM (MP Biomedicals Inc. Solon, OH, USA), a pH-sensitive fluorescent probe, was added to the cell suspension for 5 min at room temperature. After the probe was incorporated into the membrane, the cells were washed twice with 1 ml of 50 mmol l À1 phosphatebuffered saline (PBS, pH 6Á0) and resuspended in 200 ll of the same buffer. To monitor the dissipation of DpH, 2 ml of PPB (pH 7Á0) and 10 ll of the cell suspension were added to quartz cuvettes and the fluorescence was measured in a Perkin Elmer LS-50B spectrofluorometer with slit widths of 5 nm for excitation and 15 nm for emission and wavelengths of 502 and 525 nm, respectively. Once the signal had stabilized, the cells were energized with 4 ll of 2Á2 mmol l À1 glucose. The addition of glucose caused an increase in intracellular pH; therefore, a noticeable and gradual increase in the fluorescence intensity was observed. After the signal stabilized, 2 ll of 5 lmol l À1 valinomycin was added to convert the Dw to DpH. After the addition of valinomycin, the cells were treated with lactosporin, nisin (positive control), lactosporin diluent or nisin diluent (negative control). The last step included adding 2 ll of 2 lmol l À1 nigericin to dissipate the remaining DpH.
Determination of safety of lactosporin using EpiVaginal TM ectocervical tissue model
The EpiVaginal TM (VEC-100) ectocervical tissue model (MatTek Corporation, Ashland, MA, USA) was used to evaluate the safety of lactosporin for vaginal application. To determine the cytotoxic effects of lactosporin on EpiVaginal TM tissue, the protocol outlined by MatTek Corp and Dover et al. (2007) was followed. Briefly, tissues were placed in a 6-well plate containing 900 ll of DMEM-based DC-100 MM medium (MatTek) prior to exposure to the test compounds. The plate containing the tissues was placed in an incubator with 5% CO 2 for 1 h at 37°C to pre-equilibrate the tissues. After incubation for 1 h, the media were removed and replaced with 900 ll of VEC-100-MM medium and then 83 ll of lactosporin was applied on VEC-100 tissues topically in triplicate for 24, 36 and 48 h. For the 48-h exposure time, two washers were used to airlift the tissue inserts and 5 ml of the assay medium was placed in each well. Two negative controls were used for the cytotoxicity assay: sterile distilled water and an antifungal cream containing 4% miconazole nitrate (Monistat-3; Ortho McNeil Pharmaceutical, Inc., Raritan, NJ, USA) that is known to be a nontoxic preparation for vaginal application (Sawyer et al. 1975; Ozyurt et al. 2001; Ayehunie et al. 2006) . The viability measurements for these two negative controls were performed at 24, 36 and 48 h similar to lactosporin.
A spermicidal cream containing 4% nonoxynol-9 (Ortho Options Conceptrol vaginal Contraceptive Gel, Advanced Care Products, Skillman, NJ, USA) was used as the positive control because of its known toxicity to vaginal tissues for 2, 4 and 6 h. At the end of each exposure time, tissue viability was determined using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The effective time for each product to reduce the tissue viability to 50% (ET-50) was then calculated.
The viability of ectocervical cells was determined by measuring the breakdown of the yellow tetrazolium to purple formazan as only viable cells are able to carry out this reaction (Mosmann 1983) . After the completion of each exposure time for LP and the controls, the liquid in the inserts was removed and the tissues were washed with Dulbecco's phosphate-buffered saline solution (D-PBS). Test compounds were removed by gently swabbing the surface of the tissue with a sterile polyester fibre-tipped swab (Thermo-Fisher, Waltham, MA, USA). Tissues were placed in a 24-well plate, and each well was filled with 300 ll of MTT solution that was prepared in culture medium (1 mg ml À1 ). After 3-h incubation at 37°C with 5% CO 2 , the tissue inserts were removed and placed in a new 24-well plate and 1660 ll isopropanol (MatTek) was added to each well to extract the formazan. The plate was incubated at room temperature in the dark for 24 h. Then, 200 ll of this mixture was transferred to a 96-well plate and measured spectrophotometrically in triplicates at 570 nm using a plate reader (MRX revelation; Dynex Technologies, VA, USA). The percentage of tissue viability was calculated using the following equation:%viability = OD 570 (treated tissue)/OD 570 (control tissue).
Results
Antimicrobial activity of lactosporin
The lactosporin preparation used in the mode of action study was active against M. lutues (indicator strain) and G. vaginalis when tested in a well diffusion assay as reported in our previous publication (Riazi et al. 2007 ).
Measurement of potassium ion release
We evaluated the pore-forming activity of lactosporin against selected indicator strain M. luteus using a potassium-sensitive electrode. Figure 1 demonstrates the effect of antimicrobials used in our experiment on potassium release from M. luteus cells. Both lactosporin and nisin caused rapid efflux of K + ions from the membrane of the indicator organism. After the addition of MRS medium, one of our negative controls, a slight raise in K + ion concentration was observed that can be attributed to the presence of potassium in the formulation of this medium.
Lactosporin does not dissipate the transmembrane potential (Dw) of Gardnerella vaginalis
The fluorescent probe 3,3′-dipropylthiadicarbocyanine iodide (DiSC 3 (5)) was used to qualitatively assess the changes occurred by lactosporin on the transmembrane potential (Dw) of the G. vaginalis cells.
An increase in the fluorescent signal of the probe after the addition of the antimicrobial compound is indicative of the transmembrane potential collapse. The increase in the fluorescent signal is attributable to the depolarization of the cell membrane by the antimicrobial compound. In contrast to nisin that caused an immediate collapse of Dw, lactosporin did not dissipate this component of the PMF (Fig. 2) . The ionophore valinomycin was subsequently added to the cells to deplete the remaining transmembrane potential. Addition of valinomycin to the cells that were exposed to nisin did not cause any further depletion of the Dw but caused complete dissipation of Dw in cells treated with lactosporin, nisin diluent and lactosporin diluent (Fig. 3) . It can be concluded that nisin causes an instantaneous collapse of the Dw in G. vaginalis cells unlike lactosporin that has no effect on this component of the PMF.
Lactosporin causes dissipation of the transmembrane pH (DpH)
The pH-sensitive fluorescent probe BCECF-AM was used to track the changes in the transmembrane pH of the G. vaginalis cells. Ionophore valinomycin was used to convert the transmembrane potential to transmembrane pH before the addition of the antimicrobial compounds. Lactosporin and nisin both caused an immediate decrease in the fluorescent signal of the BCECF-AM probe (Fig. 4) , indicating a decrease in the internal pH of the cells. In contrast, nisin diluent and lactosporin diluent (MRS) did not have such an effect on the intracellular pH of G. vaginalis cells. Nigericin was added to deplete 
Lactosporin is a safe and noncytotoxic compound for vaginal application
The EpiVaginal TM ectocervical tissues were used to study the cytotoxic effects of lactosporin on vaginal tissues. The tissue viability was approximately 66% after a 48-h exposure to lactosporin (Fig. 4) . The viability of the tissues treated with the negative control, 4% miconazole nitrate, after 48 h was about 41%, while the positive control, nonoxynol-9, reduced the viability to 28% in 6 h. The ET-50 value for lactosporin could not be calculated because the tissue viability was not <50% at any of the time points used in this experiment. The calculated ET-50 values for nonoxynol-9 and miconazole were approximately 4 and 23 h, respectively.
Discussion
In this study, we investigated the mechanism of action of lactosporin against G. vaginalis cells in order to determine whether this antimicrobial preparation was safe for No claim to US Government works vaginal application. Our mode of action data indicated that lactosporin instantaneously dissipated the transmembrane pH gradient (DpH) of the G. vaginalis cells, while it had no effect on the transmembrane electric potential (Dw), in contrast to nisin that fully depleted both components of the PMF. Similar to lactosporin, the selective dissipation of one of the portions of the PMF has been reported for a number of other bacteriocins. For instance, Herranz et al. (2001) indicated that enterocin P did not cause any changes in the pH gradient of the Enterococcus faecium T136 cells, while it caused full depletion of the transmembrane electric potential and the release of intracellular ATP from the target cells. Subtilosin, a bacteriocin produced by Bacillus amyloliquefaciens, acts similar to lactosporin by depleting the transmembrane pH gradient and has no effect on the transmembrane electric potential of the G. vaginalis cells . (Montville and Bruno 1994) . Our previous research indicated that lactosporin is an anionic antimicrobial protein that potentially targets the membrane of sensitive cells (Riazi et al. 2009 ).The ability of lactosporin to form pores in sensitive cells of M. luteus was observed by rapid K + efflux from these cells. The K + assay requires bacterial cells to be washed with Tris-acetate buffer solution and kept on ice throughout the experiment to slow down the cells' metabolism. These conditions worked well for the indicator organism M. luteus but the fastidious G. vaginalis could not survive the assay's condition. Therefore, only the K + efflux results for M. luteus cells are presented. As reported by Van Kuijk et al. (2011) , the action of antimicrobial proteins can be species-specific; therefore, it cannot be concluded that lactosporin exerts its antimicrobial properties on G. vaginalis cells in a similar manner. The aim of this investigation was to study the effects of lactosporin on G. vaginalis cells and the reference strain M. lutues was only used when an experiment could not be performed using G. vaginalis cells.
Majority of bacteriocins have amphiphilic and cationic
Together, PMF and K + leakage data suggest that lactosporin may exert its antimicrobial activity by targeting the cytoplasmic membrane of sensitive cells and forming transient pores followed by leakage of small ions and dissipation of proton motive force. Our previous data indicated that lactosporin had antimicrobial activity against the vaginal pathogen G. vaginalis but did not have any effects on the healthy vaginal lactobacilli (Riazi et al. 2009 ). The MatTek EpiVaginal TM tissue model was used to evaluate the cytotoxic effects of lactosporin on vaginal and ectocervical epithelial cells. Our data revealed that lactosporin is a safe preparation for vaginal application to control bacterial vaginosis. The EpiVaginal TM in vitro test is gradually replacing the traditional in vivo models to study vaginal irritation because of its higher reliability and reproducibility. A prior study conducted in our laboratory evaluated the effects of an antimicrobial peptide, lactocin 160, on vaginal tissues using the EpiVaginal TM in vitro model and the in vivo rabbit vaginal irritation system ). This study confirmed that the used in vitro model is a reliable alternative for animal testing and provides higher reproducibility. In a different study, EpiVaginal TM tissue system was used to evaluate the safety of an antimicrobial peptide subtilosin .
Natural antimicrobial proteins produced by friendly bacteria have received a great deal of attention in the last decade because of the potential health problems associated with the use of chemical antimicrobial agents in foods and personal care products, and because of the rapidly growing microbial resistance to conventional antibiotics (Abee et al. 1995; Cleveland et al. 2001) . Antimicrobial resistance has become a major problem that is associated with increased negative impacts on human health and healthcare costs (Cohen 1992) . The bacterial resistance issue can be addressed by using a multiple-hurdle approach. In hurdle technology, different synergistic antimicrobial agents with different mechanisms of action are used to more efficiently inhibit the growth of target micro-organisms (Cleveland McEntire et al. 2003) . In our future research, we will explore the synergistic activity of lactosporin with other natural antimicrobial agents against G. vaginalis. This information will be used to design and formulate more effective products for the control of bacterial vaginosis. 
